$PTI News Article - Proteostasis Therapeutics to Initiate First Ever Personalized Medicine-Based Clinical Trial, CHOICES, in European CF Patients with Genotypes Ineligible for Approved CFTR Modulators
https://marketwirenews.com/news-releases/prot...12530.html